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RESUMEN
La tuberculosis, infección causada por Mycobacterium 
tuberculosis, es un problema global de salud que cau-
sa aproximadamente dos millones de muertes anuales. 
Además, se estima que un tercio de la población mun-
dial está infectada con la forma latente de este bacilo. Las 
terapias existentes contra la tuberculosis están dirigidas 
contra  bacterias que se replican activamente, mientras 
que no hay  actualmente ningún tratamiento específico 
para la infección latente de tuberculosis. Los sistemas de 
dos componentes (two-component systems, TCSs) bac-
terianos  juegan un papel central en la adaptación de las 
bacterias patógenas al medio ambiente que prevalece en 
los tejidos del huésped. Los TCSs  permiten a los microor-
ganismos detectar y responder a los cambios en diferen-
tes condiciones ambientales, y como tales se consideran 
posibles dianas terapéuticas para el diseño de nuevos 
fármacos antimicobacterianos. En esta revisión, se descri-
be el conocimiento actual de los TCS de Mycobacterium 
tuberculosis. Se discute el papel que desempeñan en la 
patogénesis bacteriana y en la virulencia, destacando  el 
sistema DosS/DosT/DosR por su papel en el desarrollo de 
la tuberculosis latente.
Palabras clave: Tuberculosis, sistema de dos componen-
tes, dianas terapéuticas,  latencia.
SUMMARY
Tuberculosis, caused by Mycobacterium tuberculosis, is 
a global health problem with approximately two million 
deaths every year. Furthermore, up to one-third of the 
world population is infected with latent form of this bac-
terium. Existing anti-tuberculosis therapies are directed 
against actively replicating bacteria, while there is no par-
ticular treatment for latent tuberculosis infection.
Bacterial two-component systems (TCSs) are pleiotropic 
and play a central role in the adaptation of pathogenic bac-
teria to the environment prevailing within host tissues. TCS 
allow microorganisms to sense and respond to changes in 
many different environmental conditions therefore are con-
sidered potential pharmacological targets for the develop-
ment of novel antimycobacterial drugs.
In this work, we review the current knowledge of the TCSs 
of Mycobacterium tuberculosis. We discuss their role in 
bacterial pathogenesis and virulence. We pay special at-
tention to the DosS/DosT/DosR TCS, emphasizing its im-
portance in latent tuberculosis development.
Keywords: Tuberculosis, two-component system, drug 
targets, latency
RESUM
La tuberculosi, infecció causada per Mycobacterium tu-
berculosis, és un problema global de salut que causa 
aproximadament dos milions de morts anuals. A més un 
terç de la població mundial està infectada amb la forma 
latent d’aquest bacil. Les teràpies existents contra la tu-
berculosi estan dirigides contra els bacteris que es repli-
quen activament, mentre que no hi ha tractament específic 
per a la infecció latent. Els sistemes de dos components 
(two-component systems, TCSs) bacterians tenen un pa-
per central en l’adaptació dels bacteris patògens al medi 
ambient que preval dins dels teixits de l’hoste. Els TCS 
permeten als microorganismes detectar i respondre als 
canvis en moltes condicions ambientals diferents, i com 
a tals es consideren potencials dianes farmacològiques 
per al disseny de nous fàrmacs antimicobacterians. En 
aquest treball, es revisa el coneixement actual dels TCSs 
de Mycobacterium tuberculosis. Es discuteix el paper que 
tenen en la patogènesi bacteriana i virulència, amb parti-
cular atenció al TCS DosS/DosT/DosR pel seu paper en el 
desenvolupament de la tuberculosi latent.
Mots clau: Tuberculosi, sistema de dos components, dia-
nes terapèutiques,  latència.
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INTRODUCTION
Tuberculosis (TB), the infectious disease caused by My-
cobacterium tuberculosis, is currently one of the major 
health problems worldwide. The World Health Organiza-
tion (WHO) estimates that one third of world’s population is 
currently infected with M. tuberculosis and approximately 
10% of these people are expected to develop active TB 
at some point in their lifetime. The development of multi-
drug-resistant and extensively drug-resistant tuberculosis 
(MDR-, XDR-TB), together with the spread of risk factors 
such as human immunodeficiency virus (HIV) and diabetes 
(Corbett et al., 2003, Restrepo et al., 2007), strengthen the 
necessity to develop new therapeutic interventions against 
tuberculosis. The current development of new antibiotics 
is not keeping pace with the rapid evolution of resistance 
to almost all clinically available drugs so alternative strate-
gies are required to fight against mycobacterial infections. 
Amongst these new therapeutic interventions, bacterial 
two-component systems (TCSs), stimulus-response cou-
pling mechanisms that allow bacteria to sense and re-
spond to changes in many different environmental condi-
tions, appear as promising new targets. 
TWO-COMPONENT SYSTEMS IN MYCOBACTERIUM 
TUBERCULOSIS
Every living organism senses changes in environmen-
tal and intracellular signals and responds accordingly to 
adapt to and survive in these new conditions. For this pur-
pose, bacteria have evolved surface-exposed signal trans-
duction systems, typically comprised of transmembrane 
proteins that channel the input from sensory modules to 
intracellular responses. These signaling systems include 
chemotaxis receptors, serine/threonine protein kinases, 
and two-component systems.
Bacterial two-component systems (TCSs) are known to 
respond to a wide variety of environmental conditions, for 
example starvation, cold/heat shock or the presence of 
antimicrobial compounds (Aguilar et al., 2001; Jordan et 
al., 2008; Sun et al., 1996).  These extracellular signals are 
transduced into the cell predominantly by TCSs, allowing 
bacteria to adapt to these new conditions (Hoch, 2000; 
Stock et al., 2000; Mascher et al., 2006; Gao et al., 2007). 
TCSs can regulate a wide variety of cellular processes, in-
cluding motility and chemotaxis, sporulation, biofilm for-
mation and quorum sensing (Jiang et al., 2000; López et 
al., 2009; Lyon & Novick, 2004; Szurmant & Ordal, 2004). 
TCSs have also been shown to play a crucial role in bac-
terial virulence (Hoch & Silhavy, 1995; Atkinson & Ninfa, 
1999).Figure 1
Figure 1. Illustration of TCS signalling pathway.
The prototypical TCS consists of a sensor histidine kinase 
(HK) that responds to a specific signal by modifying the 
phosphorylated state of its cognate response regulator 
(RR) (Figure 1). First, upon the perception of environmen-
tal or intracellular signal, HK undergoes conformational 
changes that result in autophosphorylation (using ATP as 
the phosphate source) within a single, conserved histidine 
residue in the carboxyl-terminal region of its receiver do-
main. Subsequently the phosphoryl group is transferred in 
a magnesium-dependent manner to an aspartate residue 
in the amino-terminal region of the partner RR protein. 
Phosphorylation of a RR induces structural changes of its 
Table 1. Complete two-component systems of M. tuberculosis (Bretl et al., 2011).
TCS
(HK/RR)
ORF annotation Regulation or Effect of inactivation Reference
SenX3/RegX3 Rv0490/Rv0491 Regulation of phosphate de-
pendent gene expression
(Himpens et al., 2000)
U/U/TcrA Rv0600c/Rv0601c/ Rv0602c Unknown (Hayden & Clark-Curtiss, 2004)
PhoP/PhoR Rv0757/Rv0758 Implication in regulating  produc-
tion of complex cell wall lipids
(Ludwiczak et al., 2002; 
Zahrt & Deretic, 2001)
NarL/NarS Rv0844c/Rv0845 Unknown (Parish et al., 2003)
PrrB/PrrA Rv0902c/Rv0903c Involvement in early intracellular multi-
plication during macrophage infection
(Ewann et al., 2002, 2004)
MprA/MprB Rv0981/Rv0982 Regulation of different genes engaged 
in physiology and pathogenesis
(Zahrt et al., 2003)
KdpE/KdpD Rv1027c/Rv1028c Involvement in virulence (Parish et al., 2003)
TrcS/TrcR Rv1032c/Rv1033c Unknown (Haydel et al., 1999)
 DosS-DosT/ DosR Rv3132c/Rv3133c Involvement in hypoxic adaptation (Saini et al., 2004a)
MtrB/MtrA Rv3245c/Rv3246c Proliferation in macrophages; es-
sential for Mtb viability
(Zahrt & Deretic, 2001)
TcrY/TcrX Rv3764c/Rv3765c Involvement in virulence (Parish et al., 2003)
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output domain, which can participate in DNA binding and 
transcriptional control, catalyse enzymatic reactions, bind 
RNA, or participate in protein–protein interactions (Gao et 
al., 2007; Stock et al., 2000; Galperin et al., 2001; Hoch, 
1995, 2000).
The M. tuberculosis (Mtb) genome encodes about two 
hundred regulatory proteins, which include over one hun-
dred putative transcriptional regulators, eleven complete 
TCSs (Table 1), six orphan RRs, and two orphan HKs (Cole 
et al., 1998; Tekaia et al., 1999). The number of TCSs in 
Mtb is rather low compared with other bacteria, e.g. E. coli, 
which has more than thirty. This relatively small number of 
TCS probably reflects the intracellular lifestyle of Mtb, as 
the cell environment is less variable than that confronted 
by soil bacteria or gut microbiota, or a certain degree of 
overlap in signal processing (Cimino et al., 2012). Com-
parative genomic analyses of TCSs in Mtb indicate that 
homologues of these genes exist in other representatives 
of Mycobacterium species, including M. bovis, M. avium, 
M. leprae, and M. smegmatis (Cole et al., 1998; Zahrt et al., 
2003). All of Mtb TCSs are conserved in their genetic ar-
rangement and location within the closely related M. bovis 
bacillus Calmette–Guérin (BCG) vaccine strain. 
Evidence suggests that many of the TCSs are engaged in 
sensing the host environment and adjusting bacterial tran-
scription to adapt to the new environment, including PrrB/
PrrA (Ewann et al., 2002), DosRST (Malhotra et al., 2004; 
Roberts et al., 2004), SenX3/RegX3 (Parish et al., 2003), 
MprA/B (Zahrt et al., 2003), MtrB/A (Fol et al., 2006), and 
PhoP/PhoR (Perez et al., 2001). 
Constitutive expression of pdtaR (coding for an orphaned 
RR, described as potential phosphorylation-dependent 
transcriptional antitermination regulator), dosT, and mtrA 
during intracellular growth indicates that these genes are 
likely to be involved in Mtb adaptation to life within mac-
rophages. Several studies have analysed the expression 
profiles during Mtb growth in human macrophages (Haydel 
& Clark-Curtiss, 2004; Zahrt & Deretic, 2001) and mice 
suggesting the biological role for these signal transduction 
systems in host-pathogen interactions.
The mutagenesis studies support the role of TCS in 
growth and survival (Sassetti et al., 2001), indicating that 
the senX3, kdpD and mtrA (Sassetti et al., 2003a) gene 
products are required for survival in mice and that the re-
sponse regulators PhoP, KdpE, PdatR, and MtrA, as well 
as the sensor kinases MprB, DosS and Mtr B (Sassetti et 
al., 2003b) are required for optimal growth in vitro.
A large number of experiments have pointed out at sev-
eral TCS proteins as important regulatory elements for 
virulence of the tubercle bacillus. This applies to DosR 
(Malhotra et al., 2004), RegX 3 (Parish et al., 2003), PhoP 
(Perez et al., 2001), SenX3 (Rickman et al., 2004), MprA 
(Zahrt and Deretic, 2001) and PrrA (Ewann et al., 2002). 
The most relevant features of Mtb TCSs related to viru-
lence, pathogenesis and host-pathogen interactions are 
discussed here.
a) RegX3 regulates a large and functionally diverse regu-
lon comprised of 100 genes. Several of these genes 
are involved in important physiological activities, in-
cluding energy metabolism, cell envelope maintenan-
ce, and regulatory functions (Parish et al., 2003). In 
Mtb, the system is required for virulence, with mutant 
strains showing attenuation in macrophage and mu-
rine infection models (Parish et al., 2003; Rickman et 
al., 2004; Rifat et al., 2009). 
b) PhoP/PhoR is involved in diverse aspects of meta-
bolic physiology and is required for virulence in Mtb. 
This TCS regulates genes associated with the ESX-1 
secretion system and synthesis of virulence associa-
ted lipids (Frigui et al., 2008; Gonzalo-Asensio et al., 
2008). Inactivation of phoP results in high attenuation 
of Mtb. The mutant is impaired to grow in macropha-
ges and BALB/c mice; however, it is not completely 
eliminated and persists in in vitro cultured-macropha-
ges and also in mice organs. This mutation, together 
with a deletion in fadD26, essential for the synthesis 
of one of the major mycobacterial virulence factors, 
has led to the construction of the first live-attenuated 
M. tuberculosis-based vaccine to enter clinical trials 
(Martin et al., 2006).
c) PrrB/PrrA TCS has been shown to be expressed 
during growth in human macrophages and is requi-
red for early intracellular multiplication (Ewann et al., 
2002; Graham & Clark-Curtiss, 1999; Haydel & Clark-
Curtiss, 2004) and mycobacterial viability (Haydel et 
al., 2012).
d) MprA/MprB TCS was originally described as being 
necessary for the establishment and maintenance of 
persistent infection by Mtb in mice and was conse-
quently named mpr for mycobacterium persistence 
regulator (Zahrt & Deretic, 2001). This TCS regulates 
adaptation programs in response to several environ-
mental stimuli and plays a role in virulence. It has 
been reported recently that MprAB modulates ESX-1 
function (Pang et al., 2013). ESX-1 is the prototype 
of type VII secretion systems found in some Gram-
positive bacteria, and the ESX-1 substrate ESAT-6 is 
a major virulence factor, implicated in different host-
pathogen interactions (Mishra et al., 2010; Samten et 
al., 2011).
e) kdpD is induced in Mtb under conditions of starvation 
(Betts et al., 2002).  KdpE/KdpD TCS plays a role in 
Mtb virulence and regulates turgor pressure and po-
tassium homeostasis.
f) Dos (also known as Dev) TCS is composed of two 
soluble, full-length histidine kinases, DosS and DosT 
and a single response regulator DosR (Figure 2). 
Dev TCS proteins were originally identified as DevR 
(Rv3133c) and DevS (Rv3132c) in a screen for ge-
nes differentially expressed in the virulent strain (dev) 
H37Rv compared to the avirulent H37Ra strain (Das-
gupta et al., 2000). Subsequent studies demonstra-
ted that Rv3133c was induced in the tubercle bacillus 
by hypoxia indicating that DevR is a key protein for 
adaptation of the bacillus to non-replicating survival 
in hypoxic environments. For this reason the gene 
was named dosR as a regulator of dormancy survival 
(dos) (Boon & Dick, 2012). Both gene designations re-
main in use today. 
g) MtrA/MtrB TCS regulates essential physiological 
processes, including DNA replication and cell wall 
integrity. The mtrA gene is constitutively expressed 
(Haydel and Clark-Curtiss, 2004) and MtrA/MtrB TCS 
is the only essential system in Mtb (Via et al., 1996; 
Zahrt & Deretic, 2000), while others are required un-
der specific growth conditions. Therefore this TCS 
may represent a novel therapeutic target (Bretl et al., 
2011).
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Figure 2
Figure 2. Mtb dormancy response to hypoxic conditions.
LATENT TUBERCULOSIS INFECTION: TARGETING 
DosRST TWO-COMPONENT SYSTEM
Many features make TCSs attractive targets for the de-
velopment of novel antimicrobial agents. Significant ho-
mology is shared among kinase and response regulator 
proteins of different bacterial species (Parkinson et al., 
1992), which could facilitate the design of broad-spectrum 
antimicrobials. Elucidated crystal structures of several 
RRs and HKs, which are available in public databases, are 
a very valuable asset to sustain a platform for structural-
based drug development projects.
Pathogenic bacteria, M. tuberculosis being a clear exam-
ple, use TCS signal transduction to regulate expression of 
virulence factors that are required for survival inside the 
host (Dziejman & Mekalanos, 1995; Groisman & Heffron, 
1995). The inhibition of virulence factors offers an oppor-
tunity for specific intervention at the level of host-pathogen 
interactions (Miller et al., 1989).
In Mtb, dosR and dosS are genetically linked and tran-
scriptionally coupled with each other, as well as with up-
stream Rv3134c gene (Dasgupta et al., 2000). In contrast, 
dosT does not belong to the core of DosR regulon and is 
located at the end of a highly induced cluster of genes 
regulated by DosR (Gerasimova et al., 2011). Genes dosR 
and dosS are conserved and tandemly arranged in many 
mycobacterial species (except M. leprae and M. ulcerans), 
while dosT appears to be less well conserved. DosS and 
DosT are capable of autophosphorylating at conserved 
histidine residues (His-395 and His-392, respectively), and 
both proteins can transfer the phospho-moiety to Asp-54 
of DosR (Roupie et al., 2007, Saini et al., 2004a, 2004b).
DosR upregulates a well-defined regulon of ∼48 genes in 
Mtb following exposure to hypoxia, nitric oxide (NO), car-
bon monoxide (CO), and ascorbic acid (Honaker et al., 
2009; Kumar et al., 2008, Taneja et al., 2010; Voskuil et al., 
2003). The DosR regulon controls survival of the bacilli in 
an anaerobically-induced state of dormancy and is neces-
sary for optimal transition of Mtb back to aerobic growth 
from an anaerobic or nitric oxide-induced non-respiring 
state (Leistikow et al., 2010; Rustad et al., 2009).
Existing anti-TB therapies are directed against actively rep-
licating bacteria, while there is no particular treatment for 
LTBI (latent TB infection). It is believed that the study of the 
DosRST signaling pathway will improve the understand-
ing of the dormancy response in M. tuberculosis. DosRST 
two-component system was proposed as an attractive 
target for the development of inhibitors against dormant 
organisms in different studies (Murphy & Brown, 2007; 
Lamichhane, 2010; Saini et al., 2005; Vohra, 2006.). Mur-
phy & Brown identified several genome wide trends and 
used them to guide the selection of targets for therapeutic 
development. The significant up-regulation of genes con-
trolled by dosR was included. They speculated that target-
ing DosRST TCS may not induce M. tuberculosis death 
directly, but by forcing them to leave the non-replicative 
state, bacilli would be made susceptible to currently avail-
able antimycobacterial treatments. 
A homology-based model of DosR was generated and 
used for the rational design of inhibitors (Gupta et al., 
2009). A phenylcoumarin derivative was identified by in 
silico screening and established to be a pathway spe-
cific inhibitor that appears to act by locking DosR in an 
inactive conformation. It is tempting to speculate that this 
compound is a good starting point for the development of 
novel compounds targeting DosR with the potentiality of 
becoming coadjuvants of current antimycobacterial drugs.
CONCLUDING REMARKS
Two-component systems of Mtb play essential roles in 
the virulence and pathogenesis of tuberculosis. These 
signalling transduction systems show structural features 
and biochemical activities that make them susceptible 
to inhibition and amenable to high-throughput screening 
campaigns for the development of new antimycobacte-
rial drugs. In particular, the inhibition of the DosRST TCS 
could lead to the development of a novel class of “anti-
latent Mtb” drugs.
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